Filing Flows

Filing Flows › Ultralife (ULBI) › Q1 2026

Ultralife (ULBI) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 8, 2026

Ultralife (ULBI) reported revenue of $47.4M for the first quarter 2026 (Q1 2026), -7% from a year earlier and -2% from the quarter before. Operating margin was -0.5%, net loss $471K (1.0% of revenue).

Revenue$47.4M
Year over year-7%
Quarter over quarter-2%
Operating margin-0.5%
Net earnings−$471K

Ultralife, Q1 2026: revenue $47.4M (-6% year over year), operating margin -0.5%, net loss $471K, operating cash flow $2.3M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$47.4M-2%-7%
Operating profit−$215K—-106%
Net earnings−$471K—-125%
Operating cash flow$2.3M+52%-33%
Free cash flow$1.5M+145%-40%

What changed

Revenue was $47.4M in Q1 2026, down 7% year over year and down 2% from the previous quarter. Battery & Energy Products Segment was the largest line at 93% of revenue. Battery & Energy Products Segment lost $2.2M year over year (down 5%), 66% of the total change.

Gross margin was 21.3%, down 3.8 points from Q1 2025. Operating costs exceeded revenue by $215K, an operating margin of -0.5%. Operating expenses grew 10% against a revenue fall of 7%. The fastest-growing cost line was Research & development (+23%). The quarter ended with a net loss of $471K, narrower than the previous quarter's $7.5M loss. Net interest and other expense of $448K was the main reason.

Operating cash flow was $2.3M (down 33% year over year). Non-cash charges added back $1.3M of depreciation and amortization. Working capital and other items added $1.4M. Capital expenditures of $770K left free cash flow of $1.5M.

Questions

What was Ultralife's revenue in the first quarter 2026?

Ultralife (ULBI) reported revenue of $47.4M for the first quarter 2026 (Q1 2026), -7% from a year earlier and -2% from the quarter before.

Was Ultralife profitable in the first quarter 2026?

Operating loss was $215K (-0.5% of revenue) and net loss $471K.

Open the interactive Sankey →

Source: Ultralife 10-Q on SEC EDGAR.